RYAN WILKE: Open Payments
NPI 1104186899 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$261 in 12 payments from 7 companies in 2025. Trend: 2023 $50 · 2024 $115 · 2025 $261
Food & beverage: $261
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $69 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
| ABBVIE INC. | 1 | $24 |
| Alkermes, Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $21 |
Products named: COBENFY, INVEGA SUSTENNA, REXULTI, INGREZZA, VRAYLAR, ARISTADA, Auvelity, ABILIFY ASIMTUFII.
Industry payments across CA — which companies pay providers there.
